Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Voyageur Pharmaceuticals partner Rain Cage Carbon and Toyota Tsusho Canada forge alliance for sustainable automotive solutions

Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) strategic partner Rain Cage Carbon Inc has announced a landmark co-marketing and master purchase agreement with Toyota Tsusho Canada Inc., a prominent supplier to global vehicle manufacturers and parts suppliers.

The collaboration aims to integrate Rain Cage Carbon's innovative carbon farm decarbonization initiatives into Toyota Tsusho Canada's diverse supply chains, delivering Advanced Carbon, a synthetic graphite replacement, to the Toyota Group's extensive network.

Under the terms of the agreement, Rain Cage Carbon will utilize its proprietary EDENTM Carbon Capture and Reuse System to provide Toyota Tsusho Canada with Advanced Carbon products. These materials are anticipated to play a vital role in the production of current and future electric vehicles, plug-in hybrids, hybrids, and hydrogen vehicles, demonstrating a shared dedication to environmental sustainability and cutting-edge automotive technologies.

Rain Cage Carbon leads in carbon capture and reuse technology, converting CO2 emissions into valuable Advanced and Engineered Carbons. Their sustainable and economically feasible solutions aim to diminish industrial processes' carbon footprint globally.

Voyageur Pharmaceuticals has partnered with Rain Cage Carbon to develop nanocarbon/fullerene-based contrast agents for medical imaging, utilizing Rain Cage's innovative EDEN carbon capture technology.

This collaboration aims to enhance the efficacy and safety of contrast agents by encapsulating and transporting them within nanocarbons, initially focusing on the United States and Canada with plans for global expansion as development progresses.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK